Cargando…
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial
BACKGROUND: Limited evidence exists regarding the cost and health-related quality of life (HRQoL) effects of non–muscle-invasive bladder cancer (NMIBC) recurrence and progression to muscle-invasive bladder cancer (MIBC). We examined these effects using evidence from a recent randomized control trial...
Autores principales: | Cox, Edward, Saramago, Pedro, Kelly, John, Porta, Nuria, Hall, Emma, Tan, Wei Shen, Sculpher, Mark, Soares, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427321/ https://www.ncbi.nlm.nih.gov/pubmed/32144049 http://dx.doi.org/10.1016/j.clgc.2019.12.004 |
Ejemplares similares
-
Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts
por: Soares, Marta O., et al.
Publicado: (2020) -
Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.” by Sampson, Firth, and Towse
por: Soares, Marta O., et al.
Publicado: (2021) -
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee
por: Woods, Beth, et al.
Publicado: (2017) -
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014) -
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
por: Whyte, Sophie, et al.
Publicado: (2016)